1-{5-[2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylamino]-hexyl}-3-p-tolyl-urea

ID: ALA423055

Chembl Id: CHEMBL423055

PubChem CID: 44372171

Max Phase: Preclinical

Molecular Formula: C22H31N3O4

Molecular Weight: 401.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)NCCCCC(C)NCC(O)c2ccc(O)c(O)c2)cc1

Standard InChI:  InChI=1S/C22H31N3O4/c1-15-6-9-18(10-7-15)25-22(29)23-12-4-3-5-16(2)24-14-21(28)17-8-11-19(26)20(27)13-17/h6-11,13,16,21,24,26-28H,3-5,12,14H2,1-2H3,(H2,23,25,29)

Standard InChI Key:  BORFATDBQZJMKK-UHFFFAOYSA-N

Associated Targets(non-human)

Adrb1 Beta-adrenergic receptor (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.51Molecular Weight (Monoisotopic): 401.2315AlogP: 3.41#Rotatable Bonds: 10
Polar Surface Area: 113.85Molecular Species: BASEHBA: 5HBD: 6
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.00CX Basic pKa: 12.63CX LogP: 2.24CX LogD: 0.99
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.27Np Likeness Score: -0.51

References

1. Reitz AB, Sonveaux E, Rosenkranz RP, Verlander MS, Melmon KL, Hoffman BB, Akita Y, Castagnoli N, Goodman M..  (1985)  Conjugates of catecholamines. 5. Synthesis and beta-adrenergic activity of N-(aminoalkyl)norepinephrine derivatives.,  28  (5): [PMID:2859372] [10.1021/jm50001a017]

Source